Viewpoints 9 Oct 2025 Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people STAT
News 3 Oct 2025 DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness
Viewpoints 30 Sep 2025 Le développement de médicaments pour les maladies négligées doit tenir compte des enfants Nature Africa
Scientific articles 30 Sep 2025 New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial BMJ Open
In the media 29 Sep 2025 Mobilisers on motorbikes: The complex process of involving communities in clinical trials Health Policy Watch
Scientific articles 29 Sep 2025 Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala Journal of the Brazilian Society of Tropical Medicine
Press releases 23 Sep 2025 Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral
Scientific articles 22 Sep 2025 Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans Antimicrobial Agents and Chemotherapy
Scientific articles 18 Sep 2025 Structure–activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis, the main causative agent of eumycetoma RSC Medicinal Chemistry
In the media 13 Sep 2025 Ce que le Prix Hideyo Noguchi change pour les patients africains, DNDi répond Sciences de chez Nous
Press releases 10 Feb 2025 The African Union Commission Strengthens Collaboration with the Drugs for Neglected Diseases initiative
Press releases 4 Feb 2025 Hyundai Bio (HDB) and DNDi sign MOU for joint development of Xafty-based dengue treatment
Press releases 30 Jan 2025 DNDi welcomes GHIT support for new collaboration with Eisai for dengue and Zika virus disease
Press releases 30 Jan 2025 IRD, DNDi and Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
Press releases 10 Jan 2024 Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease
Press releases 15 Dec 2023 EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
Press releases 8 Dec 2023 Nagasaki University, DNDi, and GHIT Fund sign agreement to collaborate on drug screening for Chagas disease
